We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,969

Proposed changes to the Patented Medicines Regulations and the PMPRB
  • Fasken Martineau DuMoulin LLP
  • Canada
  • December 6 2017

On December 1, 2017, the Federal Government published proposed changes to the Patented Medicines Regulations, representing the first major update to


Proposed Amendments to the Patented Medicines Regulations
  • Aird & Berlis LLP | Aird & McBurney LP
  • Canada
  • December 5 2017

Proposed regulations amending the Patented Medicines Regulations ("Regulations") were published on December 2, 2017, in the Canada Gazette Part 1 for


An exclusive look inside BlackBerry’s patent portfolio as the company continues its monetisation drive
  • IAM
  • Canada
  • December 5 2017

The last five years have been busy for BlackBerry on the patent front as it has moved from a relatively passive, defence-based strategy to one that is


Federal Court Declines Jurisdiction to Approve Third-Party Funding Agreements in the Private Litigation Context
  • PCK Perry + Currier Inc Currier + Kao LLP
  • Canada
  • December 5 2017

The practice of parties receiving funding for litigation via third-party funding agreements has ramped up in recent years. As this case demonstrates


Canada releases proposed amendments to Regulations governing patented medicines pricing
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • December 4 2017

On December 2, 2017 Canada’s Governor-in-Council published proposed Regulations Amending the Patented Medicines Regulations (“the proposed


Canada’s new linkage litigation scheme: a comparison to Hatch-Waxman
  • Smart & Biggar/Fetherstonhaugh
  • USA, Canada
  • December 1 2017

The September 21, 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme


Doing Business in Canada
  • Borden Ladner Gervais LLP
  • USA, Canada, European Union, Global
  • November 30 2017

This guide provides a practical overview of Canada’s legal landscape to international Businesses looking to establish operations in Canada or


在加拿大经商
  • Borden Ladner Gervais LLP
  • USA, Canada, European Union, Global
  • November 30 2017

本手册为考虑在加拿大投资或经商的国际企业提供了加拿大法律体系的 综合实用指南


Federal Court finds PMPRB unreasonable in finding Galderma patent 'pertains to' medicine in DIFFERIN
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • November 30 2017

In a November 9, 2017 decision, Justice Phelan of the Federal Court found that the Patented Medicine Prices Review Board Panel (Board) was


Actavis v Eli Lilly
  • Gowling WLG
  • United Kingdom, Canada, European Union
  • November 27 2017

Following the Supreme Court's decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its